Autologous Angiogenic Cell Precursors- A Molecular Strategy for The Treatment of Heart Failure: Response to Biocardia’s Cardiamp HF Trial

Fraser C Henderson*; Kelly Tuchman; Ina Sarel

**Fraser C Henderson*, Kelly Tuchman and Ina Sarel**

Volume6-Issue5
Dates: Received: 2025-05-01 | Accepted: 2025-05-08 | Published: 2025-05-12
Pages: 433-438

Abstract

FullText HTML FullText PDF DOI: 10.37871/jbres2100

Certificate of Publication

Copyright

How to cite this article

Henderson FC, Tuchman K, Sarel I. Autologous Angiogenic Cell Precursors- A Molecular Strategy for The Treatment of Heart Failure: Response to Biocardia’s Cardiamp HF Trial. J Biomed Res Environ Sci. 2025 May 12; 6(5): 433-438. doi: 10.37871/jbres2100, Article ID: JBRES2100, Available at: https://www.jelsciences.com/articles/jbres2100.pdf

Subject area(s)

Clinical Trials

Cardiovascular Diseases

Clinical Cardiology

References

Hershberger RE, Hedges DJ, Morales A. Dilated cardiomyopathy: the complexity of a diverse genetic architecture. Nat Rev Cardiol. 2013 Sep;10(9):531-47. doi: 10.1038/nrcardio.2013.105. Epub 2013 Jul 30. PMID: 23900355.
Merlo M, Stolfo D, Anzini M, Negri F, Pinamonti B, Barbati G, Ramani F, Lenarda AD, Sinagra G. Persistent recovery of normal left ventricular function and dimension in idiopathic dilated cardiomyopathy during long-term follow-up: does real healing exist? J Am Heart Assoc. 2015 Jan 13;4(1):e001504. doi: 10.1161/JAHA.114.000570. PMID: 25587018; PMCID: PMC4330074.
Lu Y, Wang Y, Lin M, Zhou J, Wang Z, Jiang M, He B. A systematic review of randomised controlled trials examining the therapeutic effects of adult bone marrow-derived stem cells for non-ischaemic dilated cardiomyopathy. Stem Cell Res Ther. 2016 Dec 9;7(1):186. doi: 10.1186/s13287-016-0441-x. PMID: 27938412; PMCID: PMC5148892.
Marquis-Gravel G, Stevens LM, Mansour S, Avram R, Noiseux N. Stem cell therapy for the treatment of nonischemic cardiomyopathy: a systematic review of the literature and meta-analysis of randomized controlled trials. Can J Cardiol. 2014 Nov;30(11):1378-84. doi: 10.1016/j.cjca.2014.03.026. Epub 2014 Mar 25. PMID: 25138483.
Schubart JR, Zare A, Fernandez-de-Castro RM, Figueroa HR, Sarel I, Tuchman K, Esposito K, Henderson FC, von Schwarz E. Safety and outcomes analysis: transcatheter implantation of autologous angiogenic cell precursors for the treatment of cardiomyopathy. Stem Cell Res Ther. 2023 Oct 26;14(1):308. doi: 10.1186/s13287-023-03539-6. PMID: 37880753; PMCID: PMC10601268.
Rong SL, Wang ZK, Zhou XD, Wang XL, Yang ZM, Li B. Efficacy and safety of stem cell therapy in patients with dilated cardiomyopathy: a systematic appraisal and meta-analysis. J Transl Med. 2019 Jul 11;17(1):221. doi: 10.1186/s12967-019-1966-4. PMID: 31296244; PMCID: PMC6624954.
Diaz-Navarro R, Urrútia G, Cleland JG, Poloni D, Villagran F, Acosta-Dighero R, Bangdiwala SI, Rada G, Madrid E. Stem cell therapy for dilated cardiomyopathy. Cochrane Database Syst Rev. 2021 Jul 21;7(7):CD013433. doi: 10.1002/14651858.CD013433.pub2. PMID: 34286511; PMCID: PMC8406792.
Menasché P. Cell therapy trials for heart regeneration - lessons learned and future directions. Nat Rev Cardiol. 2018 Nov;15(11):659-671. doi: 10.1038/s41569-018-0013-0. PMID: 29743563.
Vrtovec B, Poglajen G, Sever M, Zemljic G, Frljak S, Cerar A, Cukjati M, Jaklic M, Cernelc P, Haddad F, Wu JC. Effects of Repetitive Transendocardial CD34+ Cell Transplantation in Patients With Nonischemic Dilated Cardiomyopathy. Circ Res. 2018 Jul 20;123(3):389-396. doi: 10.1161/CIRCRESAHA.117.312170. Epub 2018 Jun 7. PMID: 29880546.
Yellon DM, Hausenloy DJ. Myocardial reperfusion injury. N Engl J Med. 2007 Sep 13;357(11):1121-35. doi: 10.1056/NEJMra071667. PMID: 17855673. 
Wang E, Zhou R, Li T, Hua Y, Zhou K, Li Y, Luo S, An Q. The Molecular Role of Immune Cells in Dilated Cardiomyopathy. Medicina (Kaunas). 2023 Jul 5;59(7):1246. doi: 10.3390/medicina59071246. PMID: 37512058; PMCID: PMC10385992.
Vujanovic L, Ballard W, Thorne SH, Vujanovic NL, Butterfield LH. Adenovirus-engineered human dendritic cells induce natural killer cell chemotaxis via CXCL8/IL-8 and CXCL10/IP-10. Oncoimmunology. 2012 Jul 1;1(4):448-457. doi: 10.4161/onci.19788. PMID: 22754763; PMCID: PMC3382881.
Walle T, Kraske JA, Liao B, Lenoir B, Timke C, von Bohlen Und Halbach E, Tran F, Griebel P, Albrecht D, Ahmed A, Suarez-Carmona M, Jiménez-Sánchez A, Beikert T, Tietz-Dahlfuß A, Menevse AN, Schmidt G, Brom M, Pahl JHW, Antonopoulos W, Miller M, Perez RL, Bestvater F, Giese NA, Beckhove P, Rosenstiel P, Jäger D, Strobel O, Pe'er D, Halama N, Debus J, Cerwenka A, Huber PE. Radiotherapy orchestrates natural killer cell dependent antitumor immune responses through CXCL8. Sci Adv. 2022 Mar 25;8(12):eabh4050. doi: 10.1126/sciadv.abh4050. Epub 2022 Mar 23. PMID: 35319989; PMCID: PMC8942354.
Ong S, Ligons DL, Barin JG, Wu L, Talor MV, Diny N, Fontes JA, Gebremariam E, Kass DA, Rose NR, Čiháková D. Natural killer cells limit cardiac inflammation and fibrosis by halting eosinophil infiltration. Am J Pathol. 2015 Mar;185(3):847-61. doi: 10.1016/j.ajpath.2014.11.023. Epub 2015 Jan 23. PMID: 25622543; PMCID: PMC4348473.
Ayach BB, Yoshimitsu M, Dawood F, Sun M, Arab S, Chen M, Higuchi K, Siatskas C, Lee P, Lim H, Zhang J, Cukerman E, Stanford WL, Medin JA, Liu PP. Stem cell factor receptor induces progenitor and natural killer cell-mediated cardiac survival and repair after myocardial infarction. Proc Natl Acad Sci U S A. 2006 Feb 14;103(7):2304-9. doi: 10.1073/pnas.0510997103. Epub 2006 Feb 7. PMID: 16467148; PMCID: PMC1413746.
Boukouaci W, Lauden L, Siewiera J, Dam N, Hocine HR, Khaznadar Z, Tamouza R, Borlado LR, Charron D, Jabrane-Ferrat N, Al-Daccak R. Natural killer cell crosstalk with allogeneic human cardiac-derived stem/progenitor cells controls persistence. Cardiovasc Res. 2014 Nov 1;104(2):290-302. doi: 10.1093/cvr/cvu208. Epub 2014 Sep 11. PMID: 25213554.
Knorr M, Münzel T, Wenzel P. Interplay of NK cells and monocytes in vascular inflammation and myocardial infarction. Front Physiol. 2014 Aug 14;5:295. doi: 10.3389/fphys.2014.00295. PMID: 25177297; PMCID: PMC4132269.
Ong S, Rose NR, Čiháková D. Natural killer cells in inflammatory heart disease. Clin Immunol. 2017 Feb;175:26-33. doi: 10.1016/j.clim.2016.11.010. Epub 2016 Nov 25. PMID: 27894980; PMCID: PMC5315604.
Vosshenrich CA, Di Santo JP. Developmental programming of natural killer and innate lymphoid cells. Curr Opin Immunol. 2013 Apr;25(2):130-8. doi: 10.1016/j.coi.2013.02.002. Epub 2013 Mar 13. PMID: 23490162.
Schömig K, Busch G, Steppich B, Sepp D, Kaufmann J, Stein A, Schömig A, Ott I. Interleukin-8 is associated with circulating CD133+ progenitor cells in acute myocardial infarction. Eur Heart J. 2006 May;27(9):1032-7. doi: 10.1093/eurheartj/ehi761. Epub 2006 Feb 2. PMID: 16455670.
Han ZJ, Li YB, Yang LX, Cheng HJ, Liu X, Chen H. Roles of the CXCL8-CXCR1/2 Axis in the Tumor Microenvironment and Immunotherapy. Molecules. 2021 Dec 27;27(1):137. doi: 10.3390/molecules27010137. PMID: 35011369; PMCID: PMC8746913.
Karin M, Lin A. NF-kappaB at the crossroads of life and death. Nat Immunol. 2002 Mar;3(3):221-7. doi: 10.1038/ni0302-221. PMID: 11875461.
Jha NK, Jha SK, Kar R, Nand P, Swati K, Goswami VK. Nuclear factor-kappa β as a therapeutic target for Alzheimer's disease. J Neurochem. 2019 Jul;150(2):113-137. doi: 10.1111/jnc.14687. Epub 2019 Mar 26. PMID: 30802950.
Díaz-Flores L, Gutiérrez R, García MP, González-Gómez M, Díaz-Flores L Jr, Carrasco JL, Madrid JF, Rodríguez Bello A. Comparison of the Behavior of Perivascular Cells (Pericytes and CD34+ Stromal Cell/Telocytes) in Sprouting and Intussusceptive Angiogenesis. Int J Mol Sci. 2022 Aug 12;23(16):9010. doi: 10.3390/ijms23169010. PMID: 36012273; PMCID: PMC9409369.
Díaz-Flores L, Gutiérrez R, García-Suárez MP, Sáez FJ, Gutiérrez E, Valladares F, Carrasco JL, Díaz-Flores L Jr, Madrid JF. Morphofunctional basis of the different types of angiogenesis and formation of postnatal angiogenesis-related secondary structures. Histol Histopathol. 2017 Dec;32(12):1239-1279. doi: 10.14670/HH-11-923. Epub 2017 Aug 1. PMID: 28762232.
Akbarian M, Bertassoni LE, Tayebi L. Biological aspects in controlling angiogenesis: current progress. Cell Mol Life Sci. 2022 Jun 7;79(7):349. doi: 10.1007/s00018-022-04348-5. PMID: 35672585; PMCID: PMC10171722.
Massa M, Rosti V, Ferrario M, Campanelli R, Ramajoli I, Rosso R, De Ferrari GM, Ferlini M, Goffredo L, Bertoletti A, Klersy C, Pecci A, Moratti R, Tavazzi L. Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction. Blood. 2005 Jan 1;105(1):199-206. doi: 10.1182/blood-2004-05-1831. Epub 2004 Sep 2. PMID: 15345590.
Banovic M, Poglajen G, Vrtovec B, Ristic A. Contemporary Challenges of Regenerative Therapy in Patients with Ischemic and Non-Ischemic Heart Failure. J Cardiovasc Dev Dis. 2022 Dec 1;9(12):429. doi: 10.3390/jcdd9120429. PMID: 36547426; PMCID: PMC9783726.
Sun Z, Wu J, Fujii H, Wu J, Li SH, Porozov S, Belleli A, Fulga V, Porat Y, Li RK. Human angiogenic cell precursors restore function in the infarcted rat heart: a comparison of cell delivery routes. Eur J Heart Fail. 2008 Jun;10(6):525-33. doi: 10.1016/j.ejheart.2008.04.004. Epub 2008 May 19. PMID: 18490195.
Brodarac A, Šarić T, Oberwallner B, Mahmoodzadeh S, Neef K, Albrecht J, Burkert K, Oliverio M, Nguemo F, Choi YH, Neiss WF, Morano I, Hescheler J, Stamm C. Susceptibility of murine induced pluripotent stem cell-derived cardiomyocytes to hypoxia and nutrient deprivation. Stem Cell Res Ther. 2015 Apr 23;6(1):83. doi: 10.1186/s13287-015-0057-6. PMID: 25900017; PMCID: PMC4445302.
Razeghian-Jahromi I, Matta AG, Canitrot R, Zibaeenezhad MJ, Razmkhah M, Safari A, Nader V, Roncalli J. Surfing the clinical trials of mesenchymal stem cell therapy in ischemic cardiomyopathy. Stem Cell Res Ther. 2021 Jun 23;12(1):361. doi: 10.1186/s13287-021-02443-1. PMID: 34162424; PMCID: PMC8220796.
Hare JM, Fishman JE, Gerstenblith G, DiFede Velazquez DL, Zambrano JP, Suncion VY, Tracy M, Ghersin E, Johnston PV, Brinker JA, Breton E, Davis-Sproul J, Schulman IH, Byrnes J, Mendizabal AM, Lowery MH, Rouy D, Altman P, Wong Po Foo C, Ruiz P, Amador A, Da Silva J, McNiece IK, Heldman AW, George R, Lardo A. Comparison of allogeneic vs autologous bone marrow–derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial. JAMA. 2012 Dec 12;308(22):2369-79. doi: 10.1001/jama.2012.25321. Erratum in: JAMA. 2013 Aug 21;310(7):750. George, Richard [added]; Lardo, Albert [added]. PMID: 23117550; PMCID: PMC4762261.
Burst VR, Gillis M, Pütsch F, Herzog R, Fischer JH, Heid P, Müller-Ehmsen J, Schenk K, Fries JW, Baldamus CA, Benzing T. Poor cell survival limits the beneficial impact of mesenchymal stem cell transplantation on acute kidney injury. Nephron Exp Nephrol. 2010;114(3):e107-16. doi: 10.1159/000262318. Epub 2009 Dec 2. PMID: 19955830.
Ikebe C, Suzuki K. Mesenchymal stem cells for regenerative therapy: optimization of cell preparation protocols. Biomed Res Int. 2014;2014:951512. doi: 10.1155/2014/951512. Epub 2014 Jan 6. PMID: 24511552; PMCID: PMC3912818.
Mathiasen AB, Jørgensen E, Qayyum AA, Haack-Sørensen M, Ekblond A, Kastrup J. Rationale and design of the first randomized, double-blind, placebo-controlled trial of intramyocardial injection of autologous bone-marrow derived Mesenchymal Stromal Cells in chronic ischemic Heart Failure (MSC-HF Trial). Am Heart J. 2012 Sep;164(3):285-91. doi: 10.1016/j.ahj.2012.05.026. PMID: 22980293.
Porat Y, Porozov S, Belkin D, Shimoni D, Fisher Y, Belleli A, Czeiger D, Silverman WF, Belkin M, Battler A, Fulga V, Savion N. Isolation of an adult blood-derived progenitor cell population capable of differentiation into angiogenic, myocardial and neural lineages. Br J Haematol. 2006 Dec;135(5):703-14. doi: 10.1111/j.1365-2141.2006.06344.x. PMID: 17052254.
Rombouts WJ, Ploemacher RE. Primary murine MSC show highly efficient homing to the bone marrow but lose homing ability following culture. Leukemia. 2003 Jan;17(1):160-70. doi: 10.1038/sj.leu.2402763. PMID: 12529674.
Arom KV, Ruengsakulrach P, Jotisakulratana V. Intramyocardial angiogenic cell precursor injection for cardiomyopathy. Asian Cardiovasc Thorac Ann. 2008 Apr;16(2):143-8. doi: 10.1177/021849230801600213. PMID: 18381874.